Cargando…
Clinical and Regulatory Concerns of Biosimilars: A Review of Literature
Although biosimilars have been part of clinical practice for more than a decade, healthcare professionals (HCPs) do not fully accept them. This is because of the perception that biosimilars may not be like their originators in terms of quality, safety, and efficacy. This study aims to evaluate the c...
Autores principales: | Halimi, Vesa, Daci, Armond, Ancevska Netkovska, Katerina, Suturkova, Ljubica, Babar, Zaheer-Ud-Din, Grozdanova, Aleksandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460311/ https://www.ncbi.nlm.nih.gov/pubmed/32796549 http://dx.doi.org/10.3390/ijerph17165800 |
Ejemplares similares
-
Current regulatory approaches for accessing potential COVID-19 therapies
por: Halimi, Vesa, et al.
Publicado: (2020) -
The use of remdesivir outside of clinical trials during the COVID-19 pandemic
por: Halimi, Vesa, et al.
Publicado: (2020) -
Immunoreactivity of glycoproteins isolated from human peripheral nerve and Campylobacter jejuni (O:19)
por: Brezovska, Katerina, et al.
Publicado: (2011) -
Authors’ reply
por: Brezovska, Katerina, et al.
Publicado: (2012) -
Antibodies to Glycoproteins Shared by Human Peripheral Nerve and Campylobacter jejuni in Patients with Multifocal Motor Neuropathy
por: Suturkova, Ljubica, et al.
Publicado: (2013)